Prazer Therapeutics

Provider of small molecule-based therapeutics for neurodegenerative diseases and refractory inflammatory diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2019 groups25 employees language prazertx.com

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon